Thrombophilia and inflammatory bowel disease: Does factor V mutation have a role?

European Journal of Gastroenterology and Hepatology

Volumn 10, Issue 10, 1998, Pages 827-829

  Över, Hülya Hamzaoǧlu ^a,b   Ülgen, Sertaç ^a   Tuǧlular, Tülin ^a   Tezel, Ahmet ^a   Avşar, Erol ^a   Geyik, Göksel ^a   Başgül, Senem ^a   Sayhan, Nur ^a   Ulusoy, Nefise ^a   Kalayci, Cem ^a   Tözün, Nurdan ^a  

^a MARMARA UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Activated protein C resistance; Crohn's disease; FV leiden; Thrombophilia; Ulcerative colitis

Indexed keywords

BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5 LEIDEN;

ADULT; AGED; ALLELE; ARTICLE; CELL MUTANT; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE MUTATION; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; THROMBOPHILIA; ULCERATIVE COLITIS;

EID: 15644374039     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199810000-00002     Document Type: Article

References (25)

1. Bargen JA, Barker W. Extensive arterial and venous thrombosis complicating chronic ulcerative colitis. Arch Intern Med 1936; 58:17-31.
2. Lam A, Borda IT, Inwood MJ, Thomson S. Coagulation studies in ulcerative colitis and Crohn's disease. Gastroenterology 1985; 68:245-251.
3. Graef V, Baggenstoss AH, Sauer WG, Spittell JA. Venous thrombosis occurring with non-specific ulcerative colitis. Arch Intern Med 1966; 117:277-282.
4. Wakefield AJ, Sawyer AM, Dhilon AP, Pittilo RM, Rowles PM, Lewis AAM, Pounder RE. Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction. Lancet 1989; 2:1057-1062.
5. Souto JC, Martinez E, Roca M, Mateo J, Pujol J, Gonzales D, Foncuberta J. Prothrombotic state and signs of endothelial lesion in plasma of patients with inflammatory bowel disease. Dig Dis Sci 1995; 40:1883-1889.
6. Chamourad P, Grunebaum L, Wiesel ML, Frey PL, Wittersheim C, Sapin R. et al. Prothrombin fragment 1 + 2 and thrombin-antithrombin III complex as markers of activation of blood coagulation in inflammatory bowel disease. Eur J Gastroenterol Hepatol 1995; 7:1183-1188.
7. Webberley MJ, Hart MT, Melikian V. Thromboembolism in inflammatory bowel disease: role of platelets. Gut 1993; 34:247-251.
8. Bertina R, Koeleman B, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369:64-67.
9. Koster T, Rosendaal FR, de Ronde H, Briet E, Vandenbroucke JP. Bertina R, et al. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden thrombophilia study. Lancet 1993; 342:1503-1506.
10. Ridker PM, Hennekens CH, Lindpainter K, Stampfer MJ, Eisenberg PR, Miletich JP. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke and venous thrombosis in apparently healthy men. N Engl J Med 1995; 332:912-917.
11. Voorberg J, Roelse J, Koopman R, Buller H, Berends F, ten Cate JW, et al. Association of idiopathic venous thromboembolism with single point-mutation at Arg 506 of factor V. Lancet 1994; 343:1535-1536.
12. Svensson P, Dahlback B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1993; 330:517-522.
13. Özbek U, Tangün Y. Frequency of factor V Leiden in Turkey. Int J Hematol 1996; 64:291-292.
14. Harvey RF, Bradshaw JM. A simple index of Crohn's disease activity. Lancet 1980; 1:514.
15. Truelove SC, Witts LJ. Cortisone in ulcerative colitis. Final report on a therapeutic trial. Br Med J 1955; 1041-1048.
16. Onken JE, Ciaccia D, Garbutt JT, Ortel TL. Activated protein C resistance phenotype in patients with inflammatory bowel disease. Gastroenterology 1997; 112:A1056.
17. Aadland E, Odegard OR, Rosth A, Try K. Free protein S deficiency in patients with Crohn's disease. Scand J Gastroenterol 1994; 29:333-335.
18. Edwards RL, Levine JB, Green R, Duffy M, Mathews E, Brande W, et al. Activation of blood coagulation in Crohn's disease. Increased plasma fibrinopeptid A levels and enhanced generation of monocyte tissue activity. Gastroenterology 1987; 92:329-337.
19. Chitolie A, Hudson M, Wakefield AJ, Riddel A, Lee CA, Pounder RE. Tissue factor inhibitor (TFPI) and factor VII in inflammatory bowel disease (IBD). Thromb Haemostas 1993; 69:A1081
20. van Wersch JWJ, Houben P, Rijken J. Platelet count, platelet activity, coagulation activity in acute phase of inflammatory bowel disease. J Clin Chem Biochem 1990; 28:513-517.
21. Dhillon AP, Anthony A, Sim R, Wakefield AJ, Sankey EA, Hudson M, et al. Mucosal capillary thrombi in rectal biopsies. Histopathology 1992; 21:127-133.
22. Wakefield AJ, Sankey EA, Dhillon AP, Sawyer AM, More L, Sim R. Granulomatous vasculitis in Crohn's disease. Gastroenterology 1991; 100:1279-1287.
23. Holdstock G, Savage D, Harman M, Wright R. Should patients with inflammatory bowel disease smoke? Br Med J 1984; 288:362.
24. Thompson NP, Wakefield AJ, Pounder RE. Inherited disorders of coagulation appear to protect against inflammatory bowel disease. Gastroenrerology 1995; 108:1011-1015.
25. Jackson L, Cronin CC, O'Gorman P, O'Connell J, Coller KP, Shanahan F. Venous thrombosis in inflammatory bowel disease: clinical setting, procoagulant profile and factor V Leiden. Gastroenterology 1997; 112:A1005.